Skip to main content
Novacyt S.A. (AIM:NCYT)
London flag London · Delayed Price · Currency is GBP · Price in GBX
39.50
+1.25 (3.27%)
May 9, 2025, 4:35 PM GMT+1

Novacyt Revenue

In the year 2024, Novacyt had annual revenue of 19.63M GBP with 69.53% growth.

Revenue
19.63M
Revenue Growth
+69.53%
P/S Ratio
1.39
Revenue / Employee
83.89K
Employees
237
Market Cap
27.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202419.63M8.05M69.53%
Dec 31, 202311.58M-9.46M-44.97%
Dec 31, 202221.04M-71.56M-77.28%
Dec 31, 202192.60M-184.60M-66.59%
Dec 31, 2020277.20M265.74M2,317.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings

Novacyt News

More News